Keryx
Biopharmaceuticals, Inc.
|
||
(Name
of Issuer)
|
||
Common
Stock, $.001 par value per share
|
||
(Title
of Class of Securities)
|
||
492515101
|
||
(CUSIP
Number)
|
||
December
31, 2008
|
||
(Date
of Event which Requires Filing of this
Statement)
|
CUSIP No. 492515101 |
13G
|
Page 2 of 3
Pages
|
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Chilton
Investment Company, LLC
87-0742367
|
|
2
|
CHECK
THE APPROPRIATE IF A MEMBER OF A GROUP (See
Instructions)
|
|
(a)
|
o
|
|
(b)
|
x
|
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
State
of Delaware
|
NUMBER
OF SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING PERSON
WITH
|
5
|
SOLE
VOTING POWER
0
|
6
|
SHARED
VOTING POWER
0
|
|
7
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
SHARED
DISPOSITIVE POWER
0
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0%
|
|
12
|
TYPE
OF REPORTING PERSON (See Instructions)
IA
|
CUSIP No. 492515101 |
13G
|
Page 3 of 3
Pages
|
Pursuant
to Rule 13d-2(b) of Regulation 13D-G under the Securities Exchange Act of
1934, as amended, the Schedule 13G initially filed on February 14, 2007 by
Chilton Investment Company, LLC (the “Reporting Person”) with respect to
the Common Stock, $0.001 par value per share (the “Common Stock”), of
Keryx Biopharmaceuticals, Inc., a Delaware corporation (the “Schedule
13G”), as amended by Amendment No. 1 to the Schedule 13G filed on February
14, 2008, is hereby amended by this Amendment No. 2 to the Schedule 13G to
report a change in the information reported in the Schedule
13G. The Schedule 13G is hereby amended as
follows:
Items
4 and 5 are hereby amended and restated in their entirety to
read:
|
|
Item
4.
|
Ownership.
|
(a) Amount
beneficially owned: 0 shares
|
|
(b) Percent
of class: 0%
|
|
(c) Number
of shares as to which the person has:
|
|
(i)
Sole power to vote or to direct the
vote: 0
(ii)
Shared power to vote or to direct the
vote: 0
(iii) Sole
power to dispose or to direct the disposition
of: 0
(iv) Shared
power to dispose or to direct the disposition
of: 0
|
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
If
this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following:
[X]
|
Chilton
Investment Company, LLC
|
|||
By: |
/s/
James Steinthal
|
||
Name: |
James
Steinthal
|
||
Title: |
Managing
Director
|